Dynamics of the transmembrane domain of the ErbB-2 receptor

被引:0
|
作者
Jean-Pierre Duneau
Serge Crouzy
Yves Chapron
Monique Genest
机构
[1]  Centre de Biophysique Moléculaire,
[2] UPR 4301 CNRS,undefined
[3] affiliated to the University of Orléans,undefined
[4] rue Charles Sadron,undefined
[5] F-45071 Orleans Cedex 02,undefined
[6] France,undefined
[7]  Département de Biologie Moléculaire et Structurale,undefined
[8] CENG,undefined
[9] CEA,undefined
[10] 17 rue des Martyrs,undefined
[11] F-38054 Grenoble Cedex 9,undefined
[12] France,undefined
来源
关键词
Key words: Molecular dynamics simulations; Transmembrane proteins; π-helix formation; π-bulge;
D O I
暂无
中图分类号
学科分类号
摘要
The structure and dynamics of the ErbB-2 transmembrane domain have been examined using molecular dynamics techniques both in vacuum and within an explicit hydrated L-α-dilauroyl-phosphatidyl-ethanolamine environment. In-vacuum simulations show that a highly cooperative structural transition occurs frequently within the α-helical transmembrane domain which converts to local π-helices. We show that the α-helix alteration does not depend upon the force field or initial side-chain conformations but is intimately related to the sequence. The membrane-like environment does not prevent the structural transition in the helix but slows down the peptide dynamics indicating that the appearance of a π-bulge is not an artifact of the vacuum approximation. The consequences of π-helix formation could be very huge for the ErbB-2 receptor which is involved in numerous human cancers and also for other membrane proteins wherein similar local structures are also observed experimentally.
引用
收藏
页码:87 / 91
页数:4
相关论文
共 50 条
  • [31] The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin
    Pinkas-Kramarski, R
    Lenferink, AEG
    Bacus, SS
    Lyass, L
    van de Poll, MLM
    Klapper, LN
    Tzahar, E
    Sela, M
    van Zoelen, EJJ
    Yarden, Y
    ONCOGENE, 1998, 16 (10) : 1249 - 1258
  • [32] The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin
    Ronit Pinkas-Kramarski
    Anne EG Lenferink
    Sarah S Bacus
    Ljuba Lyass
    Monique LM van de Poll
    Leah N Klapper
    Eldad Tzahar
    Michael Sela
    Everardus JJ van Zoelen
    Yosef Yarden
    Oncogene, 1998, 16 : 1249 - 1258
  • [33] FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion
    Benlimame, N
    He, Q
    Jie, S
    Xiao, DZ
    Xu, YJ
    Loignon, M
    Schlaepfer, DD
    Alaoui-Jamali, MA
    JOURNAL OF CELL BIOLOGY, 2005, 171 (03): : 505 - 516
  • [34] The Tyrosine Kinase Receptor HER2 (erbB-2) From Oncogenesis to Adipogenesis
    Vazquez-Martin, Alejandro
    Jose Ortega-Delgado, Francisco
    Manuel Fernandez-Real, Jose
    Menendez, Javier A.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 105 (05) : 1147 - 1152
  • [35] Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells
    Balañá, ME
    Labriola, L
    Salatino, M
    Movsichoff, F
    Peters, G
    Charreau, EH
    Elizalde, PV
    ONCOGENE, 2001, 20 (01) : 34 - 47
  • [36] Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells
    Maria Eugenia Balañá
    Leticia Labriola
    Mariana Salatino
    Federico Movsichoff
    Giselle Peters
    Eduardo H Charreau
    Patricia V Elizalde
    Oncogene, 2001, 20 : 34 - 47
  • [37] The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development
    Chan, R
    Hardy, WR
    Laing, MA
    Hardy, SE
    Muller, WJ
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (04) : 1073 - 1078
  • [38] Endosomal transport of ErbB-2: mechanism for nuclear entry of cell surface receptor
    Li, Long-Yuan
    Giri, Dipak K.
    Ali-Seyed, Mohamed
    Lee, Dung-Fang
    Ling, Pin
    Bartholomeusz, Geoffrey
    Wang, Shao-Chun
    Hung, Mien-Chie
    CANCER RESEARCH, 2006, 66 (08)
  • [39] CHARACTERIZATION AND 111In RADIOLABELING OF ErbB-2 RECEPTOR-TARGETING PEPTIDES
    Kumar, S. R.
    Quinn, T. P.
    Deutscher, S. L.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S10 - S10
  • [40] Targeting of stealth liposomes to erbB-2 (Her/2) receptor: In vitro and in vivo studies
    Goren, D
    Horowitz, AT
    Zalipsky, S
    Woodle, MC
    Yarden, Y
    Gabizon, A
    BRITISH JOURNAL OF CANCER, 1996, 74 (11) : 1749 - 1756